USANA Q1 sales hurt by Chinese campaign; LifeVantage on Track for High Annual Revenue; Avon Misses Estimates but Remains Optimistic; Mannatech Sales Flat Chinese 100-day Campaign Hurts USANA’s Q1 Sales USANA Health Science started its 2019 fiscal year slower than expected, with the company reporting soft sales for Q1 amid
This content is restricted to site members. If you are an existing user, please log in. New users may register below.